Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm
High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy
Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party
Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myeloma
Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma
Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma
Unrelated donor stem cell transplantation in adult patients with thalassemia
FLT3 mutations in normal karyotype acute myeloid leukemia in first complete remission treated with autologous peripheral blood stem cell transplantation
Significance of eosinophilia after stem cell transplantation as a possible prognostic marker for favorable outcome
Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants
Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath)
Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation
Resistance to pretransplant imatinib therapy may adversely affect the outcome of allogeneic stem cell transplantation in CML
Retinal and cerebral toxoplasmosis following nonmyeloablative stem cell transplant for chronic lymphocytic leukaemia